Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises FSN Capital in connection with the acquisition of Seriline
Mandate

Vinge advises FSN Capital in connection with the acquisition of Seriline

February 23, 2022 Intellectual Property M&A Corporate Crime & Compliance Employment and Benefits Banking and Finance IT, Telecommunications and Outsourcing Commercial Agreements

Vinge advises FSN Capital in connection with the acquisition of a majority stake in Seriline AB from its current shareholders, who will retain a sizable stake in the company.

Serline was founded in 1990 and is a provider of Identity and Access Management (IAM) solutions. Seriline offers proprietary software, online solutions, hardware and services that simplify the flow to creating user-friendly processes for confidentiality and integrity management of identities. Seriline has 29 FTEs and had SEK 84m in sales in 2021. The company is expected to be the initial platform in FSN’s buy-and-build strategy to create a Nordic cybersecurity leader within IAM.

Established in 1999, FSN Capital Partners is a leading Northern European private equity firm and investment advisor to the FSN Capital Funds, with €4 billion under management. FSN Capital Funds make control investments in growth-oriented Northern European companies, to support further growth and to transform companies into more sustainable, competitive, international, and profitable entities. 

Vinge’s team mainly consisted of Johan Winnerblad, Maria Dahlin Kolvik, Eléonore Friberg and Ebba Nyberg (M&A), Mathilda Persson and Karolina Fuhrman (IT/GDPR), Martin Boström (Commercial agreements), Felix Möller (Bank and Finance), Gustav Lindgren (Arbetsrätt), Sofia Bergenstråhle och Axel Lennartsson (IP), Tove Lövgren Frisk (Compliance), Ellinor Gyllenhammar and Elin Kollin (VDR).

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised SBP Kredit AB (publ) in connection a securitisation with a Nordic bank as senior lender

 The agreement covers a total amount of SEK 1 billion and creates conditions for significantly increased lending capacity. The agreement has been structured in accordance with the EU Securitisation Regulation and enables qualified loans to be continuously transferred to a special purpose vehicle within the SBP group.
September 14, 2026